Comparison of Treatment Outcome Between Short-Course Total Neoadjuvant Therapy vs. Neoadjuvant Long-Course Chemoradiotherapy Alone in Locally Advanced Rectal Adenocarcinoma: A Phase III Randomized Controlled Trial
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S75-S76
DOI: 10.1016/j.ijrobp.2026.06.080 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von S.K.K. Barik und 17 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Barik, S., Mukherjee, P., Mahajan, A., Das, D., Majumdar, S., Mondal, S., Muduly, D., Mishra, T., Sasmal, P., Pattnaik, B., Sahoo, B., Parta, S., Dutta, T., Swain, P., Gupta, S., Nayak, H., Mishra, S., & Parida, D. (2026). Comparison of Treatment Outcome Between Short-Course Total Neoadjuvant Therapy vs. Neoadjuvant Long-Course Chemoradiotherapy Alone in Locally Advanced Rectal Adenocarcinoma: A Phase III Randomized Controlled Trial. International Journal of Radiation Oncology*Biology*Physics, 126(1), S75-S76. https://doi.org/10.1016/j.ijrobp.2026.06.080
Vancouver
Barik S, Mukherjee P, Mahajan A, Das D, Majumdar S, Mondal S, et al. Comparison of Treatment Outcome Between Short-Course Total Neoadjuvant Therapy vs. Neoadjuvant Long-Course Chemoradiotherapy Alone in Locally Advanced Rectal Adenocarcinoma: A Phase III Randomized Controlled Trial. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S75-S76. doi:10.1016/j.ijrobp.2026.06.080
BibTeX
@article{Barik2026,
author = {Barik, S.K.K. and Mukherjee, P. and Mahajan, A. and Das, D.K. and Majumdar, S.K.D. and Mondal, S. and Muduly, D.K. and Mishra, T.S. and Sasmal, P. and Pattnaik, B. and Sahoo, B. and Parta, S. and Dutta, T. and Swain, P. and Gupta, S. and Nayak, H. and Mishra, S. and Parida, D.K.},
title = {Comparison of Treatment Outcome Between Short-Course Total Neoadjuvant Therapy vs. Neoadjuvant Long-Course Chemoradiotherapy Alone in Locally Advanced Rectal Adenocarcinoma: A Phase III Randomized Controlled Trial},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {S75--S76},
doi = {10.1016/j.ijrobp.2026.06.080}
}
EUVIMED